Brief: Clearside Biomedical To Pursue Sale Of Its Business Through Voluntary Chapter 11 Process
24/11/2025 13:27
Nov 24 (Reuters) - Clearside Biomedical Inc CLSD.O: CLEARSIDE BIOMEDICAL TO PURSUE STRATEGIC SALE OF ITS BUSINESS THROUGH VOLUNTARY CHAPTER 11 PROCESS CLEARSIDE BIOMEDICAL INC - FILES FOR CHAPTER 11 BANKRUPTCY CLEARSIDE BIOMEDICAL INC - SEEKS AUTHORIZATION FOR AUCTION AND SALE PROCESS Source text: ID:nGNX5vjW87 Further company coverage: CLSD.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Clearside Biomedical,
See all newsBrief: Clearside Biomedical Completes Financial Restructuring And Emerges From Chapter 11 With Steel Partners As Plan Sponsor
U.S. STOCKS ON THE MOVE-Merck, Genco, Tesla
U.S. STOCKS ON THE MOVE-Morgan Stanley, Merck, Genco
Clearside Biomedical plunges after filing for Chapter 11 bankruptcy
U.S. STOCKS ON THE MOVE-Bristol Myers Squibb, Palo Alto Networks, MP Materials